Literature DB >> 32888090

The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors.

Jieyu Wang1,2, Ruifang Chen1, Jun Li1, Xin Lu3,4.   

Abstract

PURPOSE: To evaluate the therapeutic role of lymphadenectomy on patients with malignant ovarian germ cell tumor (MOGCT) and to investigate the risk factors of lymph node metastasis.
METHODS: Patients of MOGCT between 1988 and 2013 with definite lymph node information were extracted from the Surveillance, Epidemiology, and End Results (SEER) database. Survival curves were estimated using the Kaplan-Meier method, and Cox regression analyses were performed to evaluate the effects of clinical and pathologic variables on survival.
RESULTS: 2424 MOGCT patients with information on lymph nodes were included. Of the entire cohort, 46.2% patients received lymphadenectomy. The most common (42.2%) histologic type was teratoma, and 70.6% patients had FIGO stage I disease. Cox proportional model verified that age, grade, and log odds of positive lymph nodes (LODDS) were independent prognostic factors. Subgroup analysis showed that the association between the lymph node resection and better survival in the different age cohort.
CONCLUSIONS: Lymphadenectomy is not recommended for children (0-14 years). For patients 40 years of age and older, and for those who have the dysgerminoma type or endodermal sinus type, lymphadenectomy had an outstanding therapeutic role. As a parameter to assess lymph node status, LODDS could be used to classify MOGCTs.

Entities:  

Keywords:  Log odds of positive lymph nodes; Lymphadenectomy; Malignant ovarian germ cell tumor; Prognosis

Mesh:

Year:  2020        PMID: 32888090     DOI: 10.1007/s00404-020-05772-3

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  25 in total

1.  Current advances in the management of malignant germ cell and sex cord-stromal tumors of the ovary.

Authors:  David M Gershenson
Journal:  Gynecol Oncol       Date:  2012-03-14       Impact factor: 5.482

Review 2.  Management of malignant ovarian germ cell tumors.

Authors:  Christine A Parkinson; Helen M Hatcher; Thankamma V Ajithkumar
Journal:  Obstet Gynecol Surv       Date:  2011-08       Impact factor: 2.347

3.  Incidence and survival rates for female malignant germ cell tumors.

Authors:  Harriet O Smith; Marianne Berwick; Claire F Verschraegen; Charles Wiggins; Letitia Lansing; Carolyn Y Muller; Clifford R Qualls
Journal:  Obstet Gynecol       Date:  2006-05       Impact factor: 7.661

Review 4.  Ratio and log odds of positive lymph nodes in breast cancer patients with mastectomy.

Authors:  Li-Ju Chen; Kuo-Piao Chung; Yao-Jen Chang; Yun-Jau Chang
Journal:  Surg Oncol       Date:  2015-05-19       Impact factor: 3.279

5.  Log odds of positive lymph nodes as a prognostic indicator in stage IV colorectal cancer patients undergoing curative resection.

Authors:  Tsuyoshi Ozawa; Soichiro Ishihara; Eiji Sunami; Joji Kitayama; Toshiaki Watanabe
Journal:  J Surg Oncol       Date:  2015-02-17       Impact factor: 3.454

6.  Comparative incidence patterns and trends of gonadal and extragonadal germ cell tumors in England, 1979 to 2003.

Authors:  Ramandeep S Arora; Robert D Alston; Tim O B Eden; Marco Geraci; Jillian M Birch
Journal:  Cancer       Date:  2012-01-17       Impact factor: 6.860

7.  Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and older.

Authors:  Darren R Feldman; Martin H Voss; Erin P Jacobsen; Xiaoyu Jia; J Andres Suarez; Stefan Turkula; Joel Sheinfeld; George J Bosl; Robert J Motzer; Sujata Patil
Journal:  Cancer       Date:  2013-04-19       Impact factor: 6.860

Review 8.  Current controversies in the management of germ cell ovarian tumours.

Authors:  Ignacio Vazquez; Gordon J S Rustin
Journal:  Curr Opin Oncol       Date:  2013-09       Impact factor: 3.645

9.  Which is the most suitable classification for colorectal cancer, log odds, the number or the ratio of positive lymph nodes?

Authors:  Yong-Xi Song; Peng Gao; Zhen-Ning Wang; Lin-Lin Tong; Ying-Ying Xu; Zhe Sun; Cheng-Zhong Xing; Hui-Mian Xu
Journal:  PLoS One       Date:  2011-12-13       Impact factor: 3.240

10.  Prediction of Cancer Incidence and Mortality in Korea, 2017.

Authors:  Kyu-Won Jung; Young-Joo Won; Chang-Mo Oh; Hyun-Joo Kong; Duk Hyoung Lee; Kang Hyun Lee
Journal:  Cancer Res Treat       Date:  2017-03-17       Impact factor: 4.679

View more
  1 in total

1.  Clinical outcome of lymphadenectomy in malignant ovarian germ cell tumors: a systematic review and meta-analysis.

Authors:  Ling Han; Yali Chen; Yana Liu; Ai Zheng; Hengxi Chen
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.